Enterprise Therapeutics raised €30M in a Series B round in Jan 2024. The company is based in UK. Investors in the round: Epidarex Capital, Forbion, IP Group and 3 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
